Author:
Bercu J.,Berlam S. C.,Berridge J.,Cherney B.,Cowley D.,Laughton H. W.,McLoughlin D.,McMahon M.,Moore C. M. V.,Murti C.,O’Neill J.,Parsons R.,Peng D. Y.,Quan R. W.,Subashi A. K.,Teasdale A.,Tyler S. M.,Watson T. J.
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science
Reference33 articles.
1. US Food and Drug Administration (USFDA). 21st Century Cures Act. Page last updated 3/29/2018.
https://www.fdagov/regulatoryinformation/lawsenforcedbyfda/significantamendmentstothefdcact/21stcenturycuresact/defaulthtm
. 2018.
2. US Food and Drug Administration (USFDA). Submission to congress: Food and Drug Administration work plan and proposed funding allocations of FDA innovation account. Required by section 1002 of the 21st Century Cures Act (Public Law 114–225). 2017.
3. International Conference on Harmonization (ICH). Q6A: specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical substances. 1999.
4. International Conference on Harmonization (ICH). Q6B: specifications: test procedures and acceptance criteria for biotechnological/biological products. 1999.
5. Yu LX. Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res. 2008;25(4):781–91.
https://doi.org/10.1007/s11095-007-9511-1
.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献